期刊文献+

蛋白激酶C在肿瘤中的作用及其抑制剂研究进展 被引量:5

The role of protein kinase C in cancer and the progress of inhibitors targeting protein kinase C
下载PDF
导出
摘要 蛋白激酶C(protein kinase C,PKC)在肿瘤的发生、发展和转移中均发挥着重要作用,因此,PKC是开发治疗肿瘤疾病药物的潜在分子靶点。目前,几种PKC抑制剂已经进入临床研究阶段,但是同时也为靶向PKC抗肿瘤药物的研究开发带来了新的挑战。该文拟对近年来蛋白激酶C在肿瘤中的作用及其抑制剂研究进展作一综述。 Protein Kinase C (PKC) plays a key role in carcinogenesis and metastasis, therefore, PKC is the potential molecular target to develop the treatments of cancer. Currently several PKC inhibitors have entered the clinical research stage, at the same time they also bring new challenges to research and development of anti-cancer drugs targeting PKC. The article will review the recent role of PKC in cancer and the progress of inhibitors targeting PKC.
出处 《中国药理学通报》 CAS CSCD 北大核心 2009年第6期708-711,共4页 Chinese Pharmacological Bulletin
基金 国家高技术研究发展计划(863计划)资助项目(No2007AA09Z405) 山东省重大科技专项资助课题(No2007GG2TC02048)
关键词 蛋白激酶C 抑制剂 肿瘤 信号传导 protein kinase C inhibitor tumor signaling transduction
  • 相关文献

参考文献25

  • 1朱钟鸣,孙耕耘.蛋白激酶Cδ亚型抑制剂对脂多糖诱导肺微血管内皮细胞损伤的影响[J].中国药理学通报,2006,22(7):800-803. 被引量:7
  • 2Los A P,de Widt J,Topham M K,et al.Protein kinase C inhibits binding of diacylglycerol kinase-zeta to the retinoblastoma protein[J].Biochim Biophys Acta,2007,1773(3):352-7.
  • 3Wu T T,Hsieh Y H,Hsieh Y S,Liu J Y.Reduction of PKC alpha decreases cell proliferation,migration,and invasion of human malignant hepatocellular carcinoma[J].J Cell Biochem,2008,103(1):9-20.
  • 4Frankel L B,Lykkesfeldt A E,Hansen J B,Stenvang J.Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells[J].Breast Cancer Res Treat,2007,104(2):165-79.
  • 5Wang Q,Zhou Y,Evers B M.Neurotensin phosphorylates GSK-3 alpha/beta through the activation of PKC in human colon cancer cells[J].Neoplasia,2006,8(9):781-7.
  • 6Guo K,Liu Y,Zhou H,et al.Involvement of protein kinase C beta-extracellular signal-regulating kinase 1/2/p38 mitogen-activated protein kinase-heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion[J].Cancer Sci,2008,99(3):486-96.
  • 7Jackson D,Zheng Y,Lyo D,et al.Suppression of cell migration by protein kinase Cδ[J].Oncogene,2005,24:3067-72.
  • 8Oliva J L,Caino M C,Senderowicz A M,Kazanietz M G.S-Phase-specific activation of PKC alpha induces senescence in non-small cell lung cancer cells[J].J Biol Chem,2008,283(9):5466-76.
  • 9Akar U,Ozpolat B,Mehta K,et al.Tissue transglutaminase inhibits autophagy in pancreatic cancer cells[J].Mol Cancer Res,2007,5(3):241-9.
  • 10Pazos Y,Alvarez C J,Camia J P,Casanueva F F.Stimulation of extracellular signal-regulated kinases and proliferation in the human gastric cancer cells KATO-Ⅲ by obestatin[J].Growth Factors,2007,25(6):373-81.

二级参考文献45

  • 1裴钢,夏国宏.蛋白激酶和蛋白磷酸脂酶的抑制剂[J].生命科学,1995,7(3):33-39. 被引量:3
  • 2孙耕耘,钱桂生,徐剑铖.全身炎症反应综合征与急性肺损伤、多器官功能障碍综合征[J].中华结核和呼吸杂志,1997,20(2):67-68. 被引量:27
  • 3Loog M, Uri A, Raidaru G. Adenosine-5'-carboxylic acid peptidyl derivatives as inhibitors of protein kinase. Bioorgnic & Medicinal Chemistry Letters, 1999, 9: 1447~1452
  • 4Scapin G. Structural biology in drug design: selective protein kinase inhibitors. DDT, 2002, 7(11): 601~611
  • 5Liu J P. Protein kinase C and its substrates. Molecular and Cellular Endocrinology, 1996, 116: 1~29
  • 6Way K J, Chou E, King G L. Identification of PKC-isoform-specific biological actions using pharmacological approaches. Tips, 2000, 21: 181~187
  • 7Fabbro D, Ruetz S, Buchdunger E, et al. Protein kinases as targets for anticancer agents: from inhibitors to useful drugs. Pharmacology & Therapeutics, 2002, 93: 79~98
  • 8Wang Z, Canagarajah B J, Boehm J C, et al. Structural basis of inhibitor selectivity in MAP kinases. Structure, 1998, 6: 1117~1128
  • 9Schinaler T, Sicheri F, Pico A, et al. Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor. Mol Cell, 1999, 3: 639~648
  • 10Hu H. Recent discovery and development of selective protein kinase C inhibitors. DDT, 1996, 1: 438~447

共引文献14

同被引文献34

  • 1赵聪,余剑波.P2X_3受体在神经病理性疼痛中的作用[J].中华临床医师杂志(电子版),2011,5(23):7056-7060. 被引量:2
  • 2白启轩,贾继东.肝纤维化发生机制及治疗进展[J].中国医学前沿杂志(电子版),2008(2):15-19. 被引量:1
  • 3吴晓玲,曾维政,蒋明德,王丕龙.肝纤维化的信号转导通路[J].世界华人消化杂志,2006,14(22):2223-2228. 被引量:33
  • 4Qian Yang Kun-Liang Guan.Expanding mTOR signaling[J].Cell Research,2007,17(8):666-681. 被引量:50
  • 5Zhang J, Anastasiadis P Z,Liu Y, et al. protein kinase C ( PKC ) betaII induces cell invasion through a ras/Mek-, PKC iota/Racl- dependent signaling pathway [ J ]. J Biol Chem, 2004, 279: 22118.
  • 6Song M G, Gao S M, Du K M, et al. Nanomolar concentration of NSC606985, a camptothecin analog, induces leukemic-cell apop- tosis through protein kinase CS-dependentmechanisms[ J]. Blood, 2005, 105(9): 3714-21.
  • 7Rahmani M, Davis E M, Bauer C. Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves down- regulation of Mcl-1 through inhibition of translation [ J ]. J Biol Chem, 2005, 280(42) : 35217 -27.
  • 8Zhu J F,Li Z J,Zhang G S,et al. Icaritin shows potent anti-Leuke- mia activity on chronic Myeloid leukemia in vitro and in vivo by regulating MAPK/ERK/.INK and JAK2/STAT3/AKT signalings [J]. PLoS ONE,2011,6(8) : e23720.
  • 9Sharkey J, Khong T, Spencer A. PKC412 demonstrates JNK-de- pendent activity against human multiple myeloma cells [ J ]. Blood, 2007,109:1712 -9.
  • 10Leytin Ⅴ.Apoptosis in the anucleate platelet.Blood Rev,2012; 26(2):51-63.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部